Eden Research plc (EDEN) - Net Assets

Latest as of June 2025: GBX10.61 Million GBX ≈ $1.29K USD

Based on the latest financial reports, Eden Research plc (EDEN) has net assets worth GBX10.61 Million GBX (≈ $1.29K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX13.46 Million ≈ $1.64K USD) and total liabilities (GBX2.85 Million ≈ $347.13 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Eden Research plc to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX10.61 Million
% of Total Assets 78.81%
Annual Growth Rate 1.39%
5-Year Change -20.71%
10-Year Change 99.73%
Growth Volatility 38.3

Eden Research plc - Net Assets Trend (2004–2024)

This chart illustrates how Eden Research plc's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Eden Research plc to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Eden Research plc (2004–2024)

The table below shows the annual net assets of Eden Research plc from 2004 to 2024. For live valuation and market cap data, see how much is Eden Research plc worth.

Year Net Assets Change
2024-12-31 GBX11.84 Million
≈ $1.44K
-12.61%
2023-12-31 GBX13.55 Million
≈ $1.65K
+26.09%
2022-12-31 GBX10.74 Million
≈ $1.31K
-16.26%
2021-12-31 GBX12.83 Million
≈ $1.56K
-14.06%
2020-12-31 GBX14.93 Million
≈ $1.82K
+103.18%
2019-12-31 GBX7.35 Million
≈ $894.00
-11.23%
2018-12-31 GBX8.28 Million
≈ $1.01K
-2.78%
2017-12-31 GBX8.51 Million
≈ $1.04K
+25.89%
2016-12-31 GBX6.76 Million
≈ $822.88
+14.11%
2015-12-31 GBX5.93 Million
≈ $721.13
-0.27%
2014-12-31 GBX5.94 Million
≈ $723.09
+4.64%
2013-12-31 GBX5.68 Million
≈ $691.04
+3.12%
2012-12-31 GBX5.51 Million
≈ $670.17
+2.27%
2011-12-31 GBX5.39 Million
≈ $655.32
+106.92%
2010-12-31 GBX2.60 Million
≈ $316.71
-45.27%
2009-12-31 GBX4.76 Million
≈ $578.67
-9.47%
2008-12-31 GBX5.25 Million
≈ $639.22
-14.72%
2007-12-31 GBX6.16 Million
≈ $749.53
+41.28%
2006-12-31 GBX4.36 Million
≈ $530.54
-31.85%
2005-12-31 GBX6.40 Million
≈ $778.44
-28.72%
2004-12-31 GBX8.98 Million
≈ $1.09K
--

Equity Component Analysis

This analysis shows how different components contribute to Eden Research plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 36662400.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock GBX5.33 Million 45.13%
Other Comprehensive Income GBX790.15K 6.69%
Other Components GBX6.41 Million 54.27%
Total Equity GBX11.82 Million 100.00%

Eden Research plc Competitors by Market Cap

The table below lists competitors of Eden Research plc ranked by their market capitalization.

Company Market Cap
GETT Gold Inc
V:GETT
$309.68K
Provexis plc
LSE:PXS
$309.69K
Windar Photonics Plc
LSE:WPHO
$310.72K
Rajvir Industries Limited
NSE:RAJVIR
$311.92K
SkinBioTherapeutics PLC
LSE:SBTX
$307.45K
International Zeolite Corp
V:IZ
$306.77K
FOXO Technologies Inc.
NYSE MKT:FOXO
$306.27K
Carclo plc
LSE:CAR
$305.51K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Eden Research plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 13,518,982 to 11,817,319, a change of -1,701,663 (-12.6%).
  • Net loss of 1,906,591 reduced equity.
  • Other comprehensive income increased equity by 31,920.
  • Other factors increased equity by 173,008.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX-1.91 Million -16.13%
Other Comprehensive Income GBX31.92K +0.27%
Other Changes GBX173.01K +1.46%
Total Change GBX- -12.59%

Book Value vs Market Value Analysis

This analysis compares Eden Research plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 142.17x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 15.43x to 142.17x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 GBX0.20 GBX3.15 x
2005-12-31 GBX0.14 GBX3.15 x
2006-12-31 GBX0.10 GBX3.15 x
2007-12-31 GBX0.13 GBX3.15 x
2008-12-31 GBX0.10 GBX3.15 x
2009-12-31 GBX0.04 GBX3.15 x
2010-12-31 GBX0.02 GBX3.15 x
2011-12-31 GBX0.06 GBX3.15 x
2012-12-31 GBX0.05 GBX3.15 x
2013-12-31 GBX0.05 GBX3.15 x
2014-12-31 GBX0.05 GBX3.15 x
2015-12-31 GBX0.04 GBX3.15 x
2016-12-31 GBX0.04 GBX3.15 x
2017-12-31 GBX0.04 GBX3.15 x
2018-12-31 GBX0.04 GBX3.15 x
2019-12-31 GBX0.04 GBX3.15 x
2020-12-31 GBX0.04 GBX3.15 x
2021-12-31 GBX0.03 GBX3.15 x
2022-12-31 GBX0.03 GBX3.15 x
2023-12-31 GBX0.03 GBX3.15 x
2024-12-31 GBX0.02 GBX3.15 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Eden Research plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -16.13%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -44.31%
  • • Asset Turnover: 0.28x
  • • Equity Multiplier: 1.30x
  • Recent ROE (-16.13%) is above the historical average (-37.03%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 -25.57% -6656.04% 0.00x 1.13x GBX-3.19 Million
2005 -40.29% 0.00% 0.00x 1.35x GBX-3.22 Million
2006 -93.85% -3990.22% 0.01x 1.74x GBX-4.53 Million
2007 -40.00% -682.91% 0.04x 1.45x GBX-3.08 Million
2008 -40.00% -2501.38% 0.01x 1.63x GBX-2.63 Million
2009 -36.31% -894.82% 0.02x 1.87x GBX-2.20 Million
2010 -124.89% -1890.12% 0.02x 3.18x GBX-3.51 Million
2011 -60.97% -3608.79% 0.01x 1.54x GBX-3.82 Million
2012 -42.07% -5315.75% 0.01x 1.38x GBX-2.87 Million
2013 -27.96% -1979.37% 0.01x 1.15x GBX-2.16 Million
2014 -49.97% -2973.78% 0.02x 1.08x GBX-3.56 Million
2015 -19.52% -131.00% 0.13x 1.13x GBX-1.75 Million
2016 -27.07% -467.17% 0.05x 1.15x GBX-2.51 Million
2017 -7.51% -34.05% 0.18x 1.24x GBX-1.49 Million
2018 -4.05% -12.07% 0.30x 1.11x GBX-1.16 Million
2019 -15.61% -62.71% 0.21x 1.21x GBX-1.88 Million
2020 -15.23% -165.84% 0.08x 1.14x GBX-3.76 Million
2021 -21.79% -227.01% 0.08x 1.17x GBX-4.07 Million
2022 -20.87% -122.44% 0.14x 1.20x GBX-3.31 Million
2023 -48.04% -203.45% 0.19x 1.23x GBX-7.85 Million
2024 -16.13% -44.31% 0.28x 1.30x GBX-3.09 Million

Industry Comparison

This section compares Eden Research plc's net assets metrics with peer companies in the Agricultural Inputs industry.

Industry Context

  • Industry: Agricultural Inputs
  • Average net assets among peers: $34,848,328
  • Average return on equity (ROE) among peers: -3.71%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Eden Research plc (EDEN) GBX10.61 Million -25.57% 0.27x $307.90K
Emmerson PLC (EML) $11.93 Million -19.05% 0.06x $341.45K
Harvest Minerals Ltd (HMI) $3.07 Million 0.00% 0.02x $16.84K
Kropz Plc (KRPZ) $113.14 Million -7.75% 0.45x $238.41K
Wynnstay Group Plc (WYN) $11.26 Million 11.95% 1.03x $980.28K

About Eden Research plc

LSE:EDEN UK Agricultural Inputs
Market Cap
$307.90K
GBX2.53 Billion GBX
Market Cap Rank
#30995 Global
#976 in UK
Share Price
GBX3.15
Change (1 day)
+0.00%
52-Week Range
GBX2.10 - GBX4.80
All Time High
GBX20.25
About

Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such a… Read more